李剑，主任医师，博士生导师。2001年毕业于北京协和医院，后长期在协和医院内科/血液内科工作。目前为血液内科科室主任。担任中华医学会血液学分会常委，北京医学会血液学分会副主委等。

长期从事浆细胞疾病和血液罕见病的研究；构建了全球最大的POEMS综合征临床队列，首次提出POEMS综合征的预后分层系统，构建了POEMS综合征的诊疗体系。优化并完善了轻链型淀粉样变的治疗模式；多学科合作开创了轻链型淀粉样变的多影像组学技术；探索了有中国特色的Castleman病的临床分型及治疗路径；相关成果被写入国内外指南和教材。承担10余项国家和省部级科研课题，在Blood等杂志发表论文80余篇。培养博士、硕士、博士后20余名。

中国足球彩票

1.Xuezhu Wang#, Kaini Shen#, Yuke Zhang, Yajuan Gao, Bowei Liu, Yubo Guo, Chao Ren, Zhenghai Huang, Xiao Li, Long Chang, Haiyan Ding, Hui Zhang, PHD, Zhuang Tian, Marcus Hacker, Shuyang Zhang, Yining Wang, Jian Li*, Xiang Li*, Li Huo. Molecular Stratification of Light-Chain Cardiac Amyloidosis with 18F-Florbetapir and 68Ga-FAPI-04 for Enhanced Prognostic Precision. JACC: Cardiovascular Imaging. 2025; 18:323-336.

2.Xuezhu Wang#, Liping Zuo#, Yanying Yu#, Xinyi Xiong, Jian Xu, Bing Qiao, Jia Chen, Hao Cai, Qi Yan, Hongxiao Han, Xin-xin Cao, Jun Deng, Chunyan Sun*, Jian Li*. Clonal Hematopoietic Mutations in Plasma Cell Disorders: Clinical Subgroups and Shared Pathogenesis. Genomics, Proteomics & Bioinformatics. 2025; 23:qzaf027.

3.Kaini Shen#, Zhuang Tian#, Yajuan Gao#, Yining Wang, Li Huo, Jian Li*, Yun Zhang*, Shuyang Zhang*; On behalf of Chinese Society of Rare Diseases and Rare Diseases Branch of China Research Hospital Association. Chinese consensus on the diagnosis and treatment of immunoglobulin light-chain cardiac amyloidosis. Chinese Medical Journal. 2024; 137:127-29.

4.Lu Zhang,# Qin-hua Liu,# Hui Zhou#, Hui-lai Zhang, Yu-jun Dong, Xiao-bo Wang, Lu-qun Wang, Li-ping Su, Xiao-jing Yan, Yan Li, Ming-zhi Zhang, Kai-yang Ding, Hui-han Wang, Hong-ling Peng, Li-ye Zhong, Lin Yang, Lin-tao Bi, Da Gao, Guang-xun Gao, Liang Huang, Chun-yan Sun, Jia Song, Wen-bin Qian, Wen-rong Huang, Zhen-ling Li, Yao Liu, Jian Li*. Asymptomatic multicentric Castleman disease: A potential early stage of idiopathic MCD. Blood Advances. 2024; 8:5598-602.

5.Lu Zhang#, Yu-jun Dong#, Hong-ling Peng#, Hao Li, Ming-zhi Zhang, Hui-han Wang, Qin-hua Liu, Li-ping Su, Li-ye Zhong, Wen-jun Wu, Liang Huang, Xiao-jing Yan, Lei Fan, Wen-jiao Tang, Zhen-ling Li, Lin-tao Bi, Yan Li, Guang-xun Gao, Li Gao, Ting-bo Liu, Yong-qiang Wei, Yao Liu, Li Yu, Hui Zhou, Chun-yan Sun, Wen-bin Qian, De-hui Zou, Hui-lai Zhang, Kai-yang Ding, Xiao-bo Wang, Ou Bai, Wen-rong Huang, Bing Chen, Lin Yang, Jia Song, Da Gao, Tong Chen, Jun Luo, Shu-ye Wang, Liang-ming Ma, David C. Fajgenbaum, Jian Li*. A national, multicenter, retrospective study of Castleman disease in China implementing CDCN criteria. The Lancet Regional Health - Western Pacific. 2023; 34:100720.

6.Jiamin Zhou#, Lu Zhang#, Xueqing Liu, Miaoyan Zhang, Jian Li*, Weihong Zhang*. The evolution of pulmonary involvement in idiopathic multicentric Castleman disease-not otherwise specified: From nodules to cysts or consolidation. Chest 2023; 164(2):418-28.

7.Xuezhu Wang#, Yubo Guo#, Yajuan Gao#, Chao Ren, Zhenghai Huang, Bowei Liu, Xiao Li, Long Chang, Kaini Shen, Haiyan Ding, DeHui Zhang, Zhuang Tian, Marcus Hacker, Shuyang Zhang, Yining Wang, Jian Li*, Xiang Li*, Li Huo*. Feasibility of 68Ga-Labeled Fibroblast Activation Protein Inhibitor Positron Emission Tomography/Computed Tomography in Light-Chain Cardiac Amyloidosis. JACC: Cardiovascular Imaging 2022; 15(11):1960-70.

8.Kai-ni Shen#, Wei-jun Fu#, Yu Wu#, Yu-jun Dong, Zhong-xia Huang, Yong-qiang Wei, Chun-rui Li, Chun-yan Sun, Ye Chen , Hui-lei Miao, Yue-lun Zhang, Xin-xin Cao, Dao-bin Zhou, and Jian Li*. Doxycycline combined with bortezomib-cyclophosphamide-dexamethasone chemotherapy for newly diagnosed cardiac light-chain amyloidosis: a multicenter randomized controlled trial. Circulation 2022; 145(1):8-1. (R)

9.Lu zhang, Ai-lin Zhao, Ming-hui Duan, Zhiyuan Li, Xinxin Cao, Jun Feng, Daobin Zhou, Dingrong Zhong, David FC, Jian Li*. Phase 2 study using oral thalidomide-cyclophosphamide-prednisone for idiopathic Multicentric Castleman disease. Blood 2019; 133(16):1720-28. (R)